Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  11 results for ""COST analysis""

Your Filters

Content Provider : Academic Search Index Publisher : elsevier b.v. Subject : drugs Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Access to and affordability of cancer medicines: time to focus on the last mile.

Subjects: *DRUGS; *TIME; *ESSENTIAL drugs

  • Source: Lancet Oncology. Oct2021, Vol. 22 Issue 10, p1342-1343. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

Management of Newer Medications for Attention-Deficit/ Hyperactivity Disorder in Commercial Health Plans.

Subjects: *ATTENTION-deficit hyperactivity disorder; *DRUGS; *MANAGEMENTUNITED States

  • Source: Clinical Therapeutics. 2014, Vol. 36 Issue 12, p2034-2046. 13p.

Record details

Read More Add to Saved list
×
Academic Journal

International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.

Subjects: *REFERENCE pricing; *DRUG prescribing; *DRUG pricesUNITED States

  • Source: Value in Health. Apr2021, Vol. 24 Issue 4, p473-476. 4p.

Record details

Read More Add to Saved list
×
Academic Journal

Value of the Rare Disease Registry of the Italian Region Friuli Venezia Giulia.

Subjects: *RARE diseases; *HEALTH planning; *MEDICAL registriesITALY

  • Source: Value in Health. Sep2019, Vol. 22 Issue 9, p1003-1011. 9p.

Record details

Read More Add to Saved list
×
Academic Journal

How can the risk that orphan drugs present to budgets be managed better?

Subjects: *DRUGS; *DRUG development; *HEALTH insurance reimbursement

  • Source: Clinical Therapeutics. Aug2010, Vol. 32 Issue 9, p1640-1641. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

A Perspective on Suitability of a Cost-Based Pricing Methodology for Repurposed Orphan Medicines: A Consideration of the Overall Value Proposition.

Subjects: *VALUE proposition; *ORPHANS; *DRUGS

  • Source: Value in Health. Jan2022, Vol. 25 Issue 1, p157-158. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis.

Subjects: *CONTROLLED release preparations; *DRUGS; *MEDLINE

  • Source: Clinical Therapeutics. Apr2015, Vol. 37 Issue 4, p691-715. 25p.

Record details

Read More Add to Saved list
×
Academic Journal

Impact of ACA on the Dinner-for-Three Dynamic.

Subjects: *DRUGS; *MANAGED care programs; *MEDICAL care

  • Source: Clinical Therapeutics. Apr2015, Vol. 37 Issue 4, p733-746. 14p.

Record details

Read More Add to Saved list
×
Academic Journal

New and Emerging Pharmacologic Therapies for Type 2 Diabetes, Dyslipidemia, and Obesity.

Subjects: *DRUG therapy for hyperlipidemia; *CLINICAL trials; *CONTROLLED release preparationsUNITED States. Food & Drug Administration

  • Source: Clinical Therapeutics. 2013, Vol. 35 Issue 1, pA3-A17. 15p.

Record details

Read More Add to Saved list
×
Academic Journal

Ulipristal Acetate: Review of the Efficacy and Safety of a Newly Approved Agent for Emergency Contraception

Subjects: *PHARMACOKINETICS; *CONTRACEPTION; *CELL receptorsNEW York (State)UNITED States. Food & Drug Administration

  • Source: Clinical Therapeutics. Jan2012, Vol. 34 Issue 1, p24-36. 13p.

Record details

Read More Add to Saved list
×
  • 1-10 of  11 results for ""COST analysis""